Author

Xiaojiang Li

Observed name: XIAOJIANG LI

Institution: Jiangsu Hengrui Medicine (China)

Observed institutions: Kunming Medical University, Changchun University of Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Jiangsu Hengrui Medicine (China)

ORCID: 0009-0008-7910-4991

Observed ORCID: 0009-0008-7910-4991

OpenAlex ID: A5036470080

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial

2026 · Yan Huang, Dongchen Sun, et al. · JAMA Oncology · 15

Research progress on the role of adipocyte exosomes in cancer progression

2024 · YUN WANG, XIAOJIANG LI, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 10

LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment

2025 · Enzi Feng, Xinyu Yang, et al. · Brazilian Journal of Otorhinolaryngology · 7

Works count: 3

Citation count: 32

H-index: 3

I10-index: 2